Original Research

Assessment of Consolidated Mail Outpatient Pharmacy Utilization in the Indian Health Service

Author and Disclosure Information

 

References

Limitations

One limitation of this study is that < 50% of the CMOP-enrolled sites (44 of 94) responded to the questionnaire. It is possible that the facilities that had a significantly positive or negative experience with CMOP were more inclined to share their views. Therefore, it is difficult to conclude whether the responding sites are an accurate representative sample. Another limitation of the study was the questionnaire design and the reliance on free-text responses as opposed to structured data. The free-text responses had to be analyzed manually to determine whether they fall in the same category, thereby increasing the risk of interpretation error.

Conclusion

CMOP has its unique challenges but provides many benefits that local pharmacy mail-out programs may not possess, such as the abilities to mail refrigerated items and track packages. One must be familiar with CMOP’s various idiosyncrasies to make the best use of the program. Extensive staff education and orientation for new staff members must be done to familiarize them with the program. Nevertheless, the successful implementation of CMOP can lead to reduced pharmacy workload while increasing access to care for patients with transportation issues.

Acknowledgments
The authors thank LCDR Karsten Smith, PharmD, BCGP, the IHS CMOP Coordinator for providing the list of primary CMOP contacts and CDR Kendall Van Tyle, PharmD, BCPS, for proofreading the article.

Pages

Recommended Reading

Cervical Pannus Without Rheumatoid Arthritis or Trauma
Federal Practitioner
The Duty to Care and Its Exceptions in a Pandemic
Federal Practitioner
Urgent and Emergent Eye Care Strategies to Protect Against COVID-19
Federal Practitioner
Where Dysphagia Begins: Polypharmacy and Xerostomia
Federal Practitioner
AHA offers advice on prehospital acute stroke triage amid COVID-19
Federal Practitioner
Robotic and manual total knee arthroplasty found at least comparable
Federal Practitioner
Analysis of Pharmacist Interventions Used to Resolve Safety Target of Polypharmacy (STOP) Drug Interactions
Federal Practitioner
Open Clinical Trials for Patients With COVID-19
Federal Practitioner
Gap Analysis for the Conversion to Area Under the Curve Vancomycin Monitoring in a Small Rural Hospital
Federal Practitioner
Beefed up inpatient/outpatient care transition is key to suicide prevention
Federal Practitioner

Related Articles

  • Pharmacology

    Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care

    The United States Public Health Service National Clinical Pharmacy Specialist Committee issues a report on the impact of pharmacy-managed clinics...